Advertisement

Osteoporosis International

, Volume 27, Issue 6, pp 2027–2033 | Cite as

The vitamin D status in ankylosing spondylitis in relation to intestinal inflammation, disease activity, and bone health: a cross-sectional study

  • E. Klingberg
  • G. Oleröd
  • O. Hammarsten
  • H. Forsblad-d’Elia
Original Article

Abstract

Summary

We assessed the vitamin D status in ankylosing spondylitis (AS) patients and healthy controls in the late winter when no vitamin D is produced by the sunlight. The vitamin D status was often poor, but not lower in AS and not associated with disease activity or signs of gut inflammation.

Introduction

The aims of the study were to investigate the vitamin D levels attained mainly by dietary intake in ankylosing spondylitis (AS) in comparison with healthy controls and in relation to gut inflammation, measured indirectly by fecal calprotectin, disease activity, osteoproliferation, bone mineral density (BMD), and vertebral fractures.

Methods

Serum 25-hydroxy vitamin D (25(OH)D) was measured in 203 AS patients and 120 healthy controls at the end of “the vitamin D winter,” when the out-door UVB irradiation is too low to allow synthesis of vitamin D3 in the skin at the latitude of Gothenburg, Sweden. Fecal calprotectin was measured in stool samples. Disease activity was assessed with CRP, ESR, ASDASCRP, BASDAI, BAS-G, BASFI, and BASMI. Lateral spine radiographs were scored for osteoproliferation and vertebral fractures using the mSASSS and Genant scores. BMD was measured in the lumbar spine and femoral neck.

Results

Vitamin D insufficiency (a serum 25(OH)D <50 nmol/L) was found in approximately 50 % of the AS patients, but serum 25(OH)D was not different from healthy controls and not significantly correlated with fecal calprotectin, gastrointestinal symptoms, disease activity parameters, mSASSS, BMD, or vertebral fractures.

Conclusions

The vitamin D status was often poor in the late winter in AS but not different from the healthy controls. No evidence for a connection between subclinical gut inflammation, malabsorption, and hypovitaminosis D was found. Serum 25(OH)D was not associated with disease activity, osteoproliferation, BMD, or vertebral fractures. We suggest that the lower vitamin D levels in AS, previously found by others, may be caused by reduced out-door UVB exposure.

Keywords

Ankylosing spondylitis Fecal calprotectin Gut inflammation Spondylarthritis Vitamin D Vitamin D deficiency 

Notes

Acknowledgments

We wish to thank all the patients and blood donors who participated in the study.

This work was supported by grants from The Health and Medical Care Executive Board of the Västra Götaland, Rune and Ulla Amlövs foundation for Rheumatology Research, Göteborg’s Association Against Rheumatism, the Medical Society of Göteborg, the Medical Society of Göteborg and the Region Västra Götaland (agreement concerning research and education of doctors), COMBINE, the Margareta Rheuma research foundation, and the Swedish Society of Medicine.

Compliance with ethical standards

Conflicts of interest

None.

Supplementary material

198_2016_3489_MOESM1_ESM.docx (16 kb)
Supplementary Table 1 (DOCX 16 kb)
198_2016_3489_MOESM2_ESM.docx (18 kb)
Supplementary Table 2 (DOCX 17 kb)

References

  1. 1.
    Wacker M, Holick MF (2013) Vitamin D—effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 5:111–148CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67:373–378CrossRefPubMedGoogle Scholar
  3. 3.
    Holick MF (2009) Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19:73–78CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Hewison M (2012) An update on vitamin D and human immunity. Clin Endocrinol 76:315–325CrossRefGoogle Scholar
  5. 5.
    Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66:1137–1142CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Gatenby P, Lucas R, Swaminathan A (2013) Vitamin D deficiency and risk for rheumatic diseases: an update. Curr Opin Rheumatol 25:184–191CrossRefPubMedGoogle Scholar
  7. 7.
    Zhao S, Duffield SJ, Moots RJ, Goodson NJ (2014) Systematic review of association between vitamin D levels and susceptibility and disease activity of ankylosing spondylitis. Rheumatology (Oxford) 53:1595–1603CrossRefGoogle Scholar
  8. 8.
    Cai G, Wang L, Fan D et al (2015) Vitamin D in ankylosing spondylitis: review and meta-analysis. Clin Chim Acta Int J Clin Chem 438:316–322CrossRefGoogle Scholar
  9. 9.
    Ghaly S, Lawrance I (2014) The role of vitamin D in gastrointestinal inflammation. Exp Rev Gastroenterol Hepatol 8:909–923CrossRefGoogle Scholar
  10. 10.
    van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMedGoogle Scholar
  11. 11.
    Klingberg E, Geijer M, Gothlin J, Mellstrom D, Lorentzon M, Hilme E, Hedberg M, Carlsten H, Forsblad-D’Elia H (2012) Vertebral fractures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skeleton. J Rheumatol 39:1987–1995CrossRefPubMedGoogle Scholar
  12. 12.
    Sieper J, Rudwaleit M, Baraliakos X et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–ii44CrossRefPubMedGoogle Scholar
  13. 13.
    Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The bath AS metrology index. J Rheumatol 21:1694–1698PubMedGoogle Scholar
  14. 14.
    Klingberg E, Olerod G, Konar J, Petzold M, Hammarsten O (2015) Seasonal variations in serum 25-hydroxy vitamin D levels in a Swedish cohort. EndocrineGoogle Scholar
  15. 15.
    Creemers MC, Franssen MJ, van’t Hof MA, Gribnau FW, van de Putte LB, van Riel PL (2005) Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 64:127–129CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148CrossRefPubMedGoogle Scholar
  17. 17.
    Engelsen O, Brustad M, Aksnes L, Lund E (2005) Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochem Photobiol 81:1287–1290CrossRefPubMedGoogle Scholar
  18. 18.
    Erten S, Kucuksahin O, Sahin A, Altunoglu A, Akyol M, Koca C (2013) Decreased plasma vitamin D levels in patients with undifferentiated spondyloarthritis and ankylosing spondylitis. Intern Med 52:339–344CrossRefPubMedGoogle Scholar
  19. 19.
    Lange U, Jung O, Teichmann J, Neeck G (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 12:1031–1035CrossRefPubMedGoogle Scholar
  20. 20.
    Lange U, Teichmann J, Strunk J, Muller-Ladner U, Schmidt KL (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16:1999–2004CrossRefPubMedGoogle Scholar
  21. 21.
    Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S, Rhodes J (1985) Vitamin D status in Crohn’s disease: association with nutrition and disease activity. Gut 26:1197–1203CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Mouli VP, Ananthakrishnan AN (2014) Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther 39:125–136CrossRefPubMedGoogle Scholar
  23. 23.
    Klingberg E, Lorentzon M, Mellstrom D, Geijer M, Gothlin J, Hilme E, Hedberg M, Carlsten H, Forsblad-d’Elia H (2012) Osteoporosis in ankylosing spondylitis—prevalence, risk factors and methods of assessment. Arthritis Res Ther 14:R108CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, Schatteman L, Elewaut D (1995) The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 22:2273–2278PubMedGoogle Scholar
  25. 25.
    Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppala K (1994) High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum 37:23–31CrossRefPubMedGoogle Scholar
  26. 26.
    Van Praet L, Jacques P, Van den Bosch F, Elewaut D (2012) The transition of acute to chronic bowel inflammation in spondyloarthritis. Nat Rev Rheumatol 8:288–295CrossRefPubMedGoogle Scholar
  27. 27.
    Klingberg E, Carlsten H, Hilme E, Hedberg M, Forsblad-d’Elia H (2012) Calprotectin in ankylosing spondylitis - frequently elevated in feces, but normal in serum. Scand J GastroenterolGoogle Scholar
  28. 28.
    Roseth AG, Schmidt PN, Fagerhol MK (1999) Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 34:50–54CrossRefPubMedGoogle Scholar
  29. 29.
    Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Seibold F (2010) Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn’s disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol 105:162–169CrossRefPubMedGoogle Scholar
  30. 30.
    Meucci G, D’Inca R, Maieron R et al (2010) Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: a multicenter prospective study. Dig Liver Dis 42:191–195CrossRefPubMedGoogle Scholar
  31. 31.
    Teichmann J, Voglau MJ, Lange U (2010) Antibodies to human tissue transglutaminase and alterations of vitamin D metabolism in ankylosing spondylitis and psoriatic arthritis. Rheumatol Int 30:1559–1563CrossRefPubMedGoogle Scholar
  32. 32.
    Durmus B, Altay Z, Baysal O, Ersoy Y (2012) Does vitamin D affect disease severity in patients with ankylosing spondylitis? Chin Med J 125:2511–2515PubMedGoogle Scholar
  33. 33.
    Arends S, Spoorenberg A, Bruyn GA, Houtman PM, Leijsma MK, Kallenberg CG, Brouwer E, van der Veer E (2011) The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis. Osteoporos Int 22:1431–1439CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Mermerci Baskan B, Pekin Dogan Y, Sivas F, Bodur H, Ozoran K (2010) The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol Int 30:375–381CrossRefPubMedGoogle Scholar
  35. 35.
    Yazmalar L, Ediz L, Alpayci M, Hiz O, Toprak M, Tekeoglu I (2013) Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis. Afr Health Sci 13:47–55PubMedPubMedCentralGoogle Scholar
  36. 36.
    Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930CrossRefPubMedGoogle Scholar
  37. 37.
    Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117–121CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Klingberg E, Lorentzon M, Gothlin J, Mellstrom D, Geijer M, Ohlsson C, Atkinson EJ, Khosla S, Carlsten H, Forsblad-d’Elia H (2013) Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes. Arthritis Res Ther 15:R179CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Mitra D, Elvins DM, Speden DJ, Collins AJ (2000) The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology (Oxford) 39:85–89CrossRefGoogle Scholar
  41. 41.
    Arunabh S, Pollack S, Yeh J, Aloia JF (2003) Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88:157–161CrossRefPubMedGoogle Scholar
  42. 42.
    Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G (2010) Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromso study. Eur J Nutr 49:401–407CrossRefPubMedGoogle Scholar
  43. 43.
    Hermann AP, Brot C, Gram J, Kolthoff N, Mosekilde L (2000) Premenopausal smoking and bone density in 2015 perimenopausal women. J Bone Miner Res 15:780–787CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2016

Authors and Affiliations

  • E. Klingberg
    • 1
  • G. Oleröd
    • 2
  • O. Hammarsten
    • 2
  • H. Forsblad-d’Elia
    • 1
    • 3
  1. 1.Department of Rheumatology and Inflammation ResearchSahlgrenska Academy at the University of GothenburgGothenburgSweden
  2. 2.Department of Clinical Chemistry and Transfusion MedicineSahlgrenska Academy at the University of GothenburgGothenburgSweden
  3. 3.Department of Public Health and Clinical Medicine, RheumatologyUmeå UniversityUmeåSweden

Personalised recommendations